Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017:2017:2823671.
doi: 10.1155/2017/2823671. Epub 2017 Sep 14.

Antidiabetic Effect of Brain-Derived Neurotrophic Factor and Its Association with Inflammation in Type 2 Diabetes Mellitus

Affiliations
Review

Antidiabetic Effect of Brain-Derived Neurotrophic Factor and Its Association with Inflammation in Type 2 Diabetes Mellitus

Ceren Eyileten et al. J Diabetes Res. 2017.

Abstract

Brain-derived neurotrophic factor (BDNF) is a neurotrophin, which plays an important role in the central nervous system, and systemic or peripheral inflammatory conditions, such as acute coronary syndrome and type 2 diabetes mellitus (T2DM). BDNF is also expressed in several nonneuronal tissues, and platelets are the major source of peripheral BDNF. Here, we reviewed the potential role of BDNF in platelet reactivity in T2DM and its association with selected inflammatory and platelet activation mediators. Besides that, we focused on adipocytokines such as leptin, resistin, and adiponectin which are considered to take part in inflammation and both lipid and glucose metabolism in diabetic patients as previous studies showed the relation between adipocytokines and BDNF. We also reviewed the evidences of the antidiabetic effect of BDNF and the association with circulating inflammatory cytokines in T2DM.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Brain-derived neurotrophic factor (BDNF) and its role on glucose haemostasis and potential relation with inflammation and type 2 diabetes mellitus (T2DM). MC4-R: melanocortin 4 receptor; TrkB: tropomyosin receptor kinase B; IL-6: interleukin 6; TNF-α: tumor necrosis factor alpha; CRP: c-reactive protein; PBMC: peripheral blood mononuclear cell.

References

    1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2009;32(Supplement 1):S62–S67. doi: 10.2337/dc09-S062. - DOI - PMC - PubMed
    1. Lontchi-Yimagou E., Sobngwi E., Matsha T. E., Kengne A. P. Diabetes mellitus and inflammation. Current Diabetes Reports. 2013;13(3):435–444. doi: 10.1007/s11892-013-0375-y. - DOI - PubMed
    1. Mattson M. P., Maudsley S., Martin B. BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders. Trends in Neurosciences. 2004;27:589–594. doi: 10.1016/j.tins.2004.08.001. - DOI - PubMed
    1. Cohen-Cory S., Kidane A. H., Shirkey N. J., Marshak S. Brain-derived neurotrophic factor and the development of structural neuronal connectivity. Developmental Neurobiology. 2010;70:271–288. doi: 10.1002/dneu.20774. - DOI - PMC - PubMed
    1. Mirowska-Guzel D. The role of neurotrophic factors in the pathology and treatment of multiple sclerosis. Immunopharmacology and Immunotoxicology. 2009;31(1):32–38. doi: 10.1080/08923970802379819. - DOI - PubMed

MeSH terms